{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:31:39Z","timestamp":1775151099779,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-2530-7","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T11:33:21Z","timestamp":1448969601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program"],"prefix":"10.1186","volume":"15","author":[{"given":"La\u2019Marcus T.","family":"Wingate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret S.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"de la Motte Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weigong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Cetron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"issue":"11","key":"2530_CR1","first-page":"201","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. Trends in tuberculosis - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(11):201\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2530_CR2","doi-asserted-by":"publisher","first-page":"e27405","DOI":"10.1371\/journal.pone.0027405","volume":"6","author":"PM Ricks","year":"2011","unstructured":"Ricks PM, Cain KP, Oeltmann JE, Kammerer JS, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005\u20132009. PLoS One. 2011;6(11):e27405.","journal-title":"PLoS One"},{"issue":"RR-6","key":"2530_CR3","first-page":"1","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49(RR-6):1\u201351.","journal-title":"MMWR Recomm Rep"},{"key":"2530_CR4","unstructured":"Olson CK, Naughton MP, Ortega LS. Newly arrived immigrants and refugees. In: Yellow Book. Centers for Disease Control and Prevention; 2015. http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2016\/advisingtravelers-with-specific-needs\/newly-arrived-immigrants-refugees . Accessed 30 Nov 2015."},{"key":"2530_CR5","unstructured":"Centers for Disease Control and Prevention: Tuberculosis screening and treatment technical instructions (TB TIs) using cultures and directly observed therapy (DOT) for panel physicians 2013. http:\/\/www.cdc.gov\/immigrantrefugeehealth\/exams\/ti\/panel\/tuberculosis-panel-technical-instructions.html (2013). Accesed 2 Nov 2013."},{"issue":"7","key":"2530_CR6","first-page":"1","volume":"62","author":"D Lee","year":"2013","unstructured":"Lee D, Philen R, Wang Z, McSpadden P, Posey DL, Ortega LS, et al. Disease surveillance among newly arriving refugees and immigrants - electronic disease notification system, United States, 2009. MMWR Surveill Summ. 2013;62(7):1\u201320.","journal-title":"MMWR Surveill Summ"},{"issue":"23","key":"2530_CR7","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1056\/NEJMoa0809497","volume":"360","author":"Y Liu","year":"2009","unstructured":"Liu Y, Weinberg MS, Ortega LS, Painter JA, Maloney SA. Overseas screening for tuberculosis in U.S.-bound immigrants and refugees. N Engl J Med. 2009;360(23):2406\u201315.","journal-title":"N Engl J Med"},{"key":"2530_CR8","doi-asserted-by":"publisher","first-page":"e32158","DOI":"10.1371\/journal.pone.0032158","volume":"7","author":"Y Liu","year":"2012","unstructured":"Liu Y, Painter JA, Posey DL, Cain KP, Weinberg MS, Maloney SA, et al. Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States. PLoS One. 2012;7:e32158.","journal-title":"PLoS One"},{"key":"2530_CR9","unstructured":"Office of Refugee Resettlement: Health insurance. http:\/\/www.Acf.Hhs.Gov\/programs\/orr\/health ] (2013). Accessed 1 April 2014."},{"issue":"3","key":"2530_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jama.2012.7505","volume":"308","author":"FM Gordin","year":"2012","unstructured":"Gordin FM, Masur H. Current approaches to tuberculosis in the United States. JAMA. 2012;308(3):283\u20139.","journal-title":"JAMA"},{"issue":"23","key":"2530_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365(23):2155\u201366.","journal-title":"N Engl J Med"},{"issue":"48","key":"2530_CR12","first-page":"1650","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60(48):1650\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2530_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10900-009-9175-3","volume":"34","author":"MD Morris","year":"2009","unstructured":"Morris MD, Popper ST, Rodwell TC, Brodine SK, Brouwer KC. Healthcare barriers of refugees post resettlement. J Community Health. 2009;34(6):529\u201338.","journal-title":"J Community Health"},{"issue":"5","key":"2530_CR14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4269\/ajtmh.2008.78.754","volume":"78","author":"JJ Shah","year":"2008","unstructured":"Shah JJ, Maloney SA, Liu Y, Flagg EW, Johnston JP, Young SA, et al. Evaluation of the impact of overseas pre-departure treatment for infection with intestinal parasites and Montagnard refugees migrating from Cambodia to North Carolina. Am J Trop Med Hyg. 2008;78(5):754\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2530_CR15","unstructured":"Centers for Disease Control and Prevention: Guidelines for screening for tuberculosis infection and disease during the domestic medical examination of newly arrived refugees. http:\/\/www.Cdc.Gov\/immigrantrefugeehealth\/guidelines\/domestic\/tuberculosis-guidelines.Html (2012). Accessed 18 Nov 2013."},{"issue":"6","key":"2530_CR16","first-page":"325","volume":"77","author":"P Gacek","year":"2013","unstructured":"Gacek P, Sosa L, Lobato MN. Assessment of postarrival tuberculosis examinations among immigrants and refugees screened overseas. Conn Med. 2013;77(6):325\u201330.","journal-title":"Conn Med"},{"issue":"7","key":"2530_CR17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2105\/AJPH.2014.302287","volume":"105","author":"JB Nuzzo","year":"2015","unstructured":"Nuzzo JB, Golub JE, Chaulk P, Sham M. Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department. Am J Public Health. 2015;105(7):1432\u20138.","journal-title":"Am J Public Health"},{"key":"2530_CR18","unstructured":"Annual Report: Texas department of state health services refugee health screening program. https:\/\/www.dshs.state.tx.us\/idcu\/health\/refugee_health\/ (2014). Accessed August 29 2015."},{"key":"2530_CR19","unstructured":"Annual report of refugee arrival notifications and health screenings in 2013. Harrisburg, Pennsylvania: Pennsylvania Department of Health; 2014."},{"key":"2530_CR20","doi-asserted-by":"publisher","unstructured":"Walters JK, Sullivan AD. Impact of routine quantiferon testing on latent tuberculosis diagnosis and treatment in refugees in multnomah county, oregon, november 2009-october 2012. J Immigr Minor Health. 2015. doi: 10.1007\/s10903-015-0187-z .","DOI":"10.1007\/s10903-015-0187-z"},{"issue":"4","key":"2530_CR21","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.2105\/AJPH.2013.301637","volume":"104","author":"RJ Bennett","year":"2014","unstructured":"Bennett RJ, Brodine S, Waalen J, Moser K, Rodwell TC. Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in san diego county, january 2010-october 2012. Am J Public Health. 2014;104(4):e95\u2013102.","journal-title":"Am J Public Health"},{"issue":"5","key":"2530_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5588\/ijtld.14.0729","volume":"19","author":"P Subedi","year":"2015","unstructured":"Subedi P, Drezner KA, Dogbey MC, Newbern EC, Yun K, Scott KC, et al. Evaluation of latent tuberculosis infection and treatment completion for refugees in philadelphia, pa, 2010\u20132012. Int J Tuberc Lung Dis. 2015;19(5):565\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2530_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10903-013-9882-9","volume":"17","author":"JB Nuzzo","year":"2015","unstructured":"Nuzzo JB, Golub JE, Chaulk P, Sham M. Analysis of latent tuberculosis infection treatment adherence among refugees and other patient groups referred to the baltimore city health department tb clinic, february 2009-march 2011. J Immigr Minor Health. 2015;17(1):56\u201365.","journal-title":"J Immigr Minor Health"},{"issue":"1","key":"2530_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1708-8305.2006.00083.x","volume":"14","author":"P Varkey","year":"2007","unstructured":"Varkey P, Jerath AU, Bagniewski SM, Lesnick TG. The epidemiology of tuberculosis among primary refugee arrivals in minnesota between 1997 and 2001. J Travel Med. 2007;14(1):1\u20138.","journal-title":"J Travel Med"},{"issue":"5","key":"2530_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/cid\/cis927","volume":"56","author":"SJ Chai","year":"2013","unstructured":"Chai SJ, Davies-Cole J, Cookson ST. Infectious disease burden and vaccination needs among asylees versus refugees, district of columbia. Clin Infect Dis. 2013;56(5):652\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2530_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5588\/ijtld.12.0439","volume":"17","author":"K Kowatsch-Beyer","year":"2013","unstructured":"Kowatsch-Beyer K, Norris-Turner A, Love R, Denkowski P, Wang SH. Utilization of a latent tuberculosis infection referral system by newly resettled refugees in central Ohio. Int J Tuberc Lung Dis. 2013;17(3):320\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"2530_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","volume":"177","author":"DE Bennett","year":"2008","unstructured":"Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, et al. Prevalence of tuberculosis infection in the united states population: The national health and nutrition examination survey, 1999\u20132000. Am J Respir Crit Care Med. 2008;177(3):348\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"2530_CR28","unstructured":"International Organization for Migration. Migration health annual review 2012. http:\/\/publications.iom.int\/bookstore\/free\/MHD_AR_2012_11Sept2013.pdf (2013). Accessed March 17, 2015."},{"key":"2530_CR29","first-page":"92","volume-title":"Prevention effectiveness a guide to decision analysis and economic evaluation","author":"PS Corso","year":"2003","unstructured":"Corso PS, Haddix AC. Time effects. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness a guide to decision analysis and economic evaluation. New York: Oxford University Press; 2003. p. 92\u2013102."},{"key":"2530_CR30","unstructured":"CDC wonder: Multiple cause of death data. Centers for Disease Control and Prevention, Atlanta. 2013. http:\/\/wonder.Cdc.Gov\/mcd.Html . Accessed 19 Feb 2014."},{"key":"2530_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/1471-2334-12-360","volume":"12","author":"M Shah","year":"2012","unstructured":"Shah M, Miele K, Choi H, DiPietro D, Martins-Evora M, Marsiglia V, et al. Quantiferon-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: A cost-effectiveness analysis. BMC Infect Dis. 2012;12:360.","journal-title":"BMC Infect Dis"},{"key":"2530_CR32","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59:1\u201325.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2530_CR33","first-page":"16","volume":"11","author":"O Oxlade","year":"2007","unstructured":"Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuber Lung Dis. 2007;11(1):16\u201326.","journal-title":"Int J Tuber Lung Dis"},{"issue":"11","key":"2530_CR34","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: What is the absolute effect of bcg and non-tuberculous mycobacteria? Int J Tuber Lung Dis. 2006;10(11):1192\u2013204.","journal-title":"Int J Tuber Lung Dis"},{"issue":"1","key":"2530_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/ajrccm.164.1.2010108","volume":"164","author":"TF Jones","year":"2001","unstructured":"Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: A cost-effectiveness analysis. Am J Respir Crit Care Med. 2001;164(1):77\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"2530_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5588\/ijtld.10.0370","volume":"15","author":"P Lowenthal","year":"2011","unstructured":"Lowenthal P, Westenhouse J, Moore M, Posey DL, Watt JP, et al. Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis. 2011;15:761\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2530_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1022903808812","volume":"5","author":"AE Vergara","year":"2003","unstructured":"Vergara AE, Miller JM, Martin DR, Cookson ST. A survey of refugee health assessments in the United States. J Immigr Health. 2003;5(2):67\u201373.","journal-title":"J Immigr Health"},{"issue":"2","key":"2530_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh Jr","year":"2010","unstructured":"Horsburgh Jr CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, et al. Latent TB infection treatment acceptance and completion in the United states and Canada. Chest. 2010;137(2):401\u20139.","journal-title":"Chest"},{"issue":"11","key":"2530_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","volume":"179","author":"DP Holland","year":"2009","unstructured":"Holland DP, Sanders GD, Hamilton CD, Stout JE. Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med. 2009;179(11):1055\u201360.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2530_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/aje\/kwt246","volume":"179","author":"KM Shea","year":"2014","unstructured":"Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh Jr CR. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014;179(2):216\u201325.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2530_CR41","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3201\/eid1105.041107","volume":"11","author":"T Cohen","year":"2005","unstructured":"Cohen T, Murray M. Incident tuberculosis among recent us immigrants and exogenous reinfection. Emerg Infect Dis. 2005;11(5):725\u20138.","journal-title":"Emerg Infect Dis"},{"key":"2530_CR42","unstructured":"The World Bank Group. Price Level ratio of PPP conversion factor (GDP) to market exchange rate. 2015. http:\/\/data.worldbank.org\/indicator\/PA.NUS.PPPC.RF . Accessed 30 Nov 2015."},{"key":"2530_CR43","unstructured":"Physician's fee and coding guide 2012. Atlanta: Mag Mutual Healthcare Solutions; 2012."},{"key":"2530_CR44","unstructured":"Salary Scales for Staff in the General Service and Related Categories. United Nations, New York. 2013. http:\/\/www.un.org\/Depts\/OHRM\/salaries_allowances\/salaries\/gs.htm . Accessed 5 Nov 2013."},{"key":"2530_CR45","unstructured":"World Economic Outlook Database. International Monetary Fund, Washington D.C. 2013. http:\/\/www.Imf.Org\/external\/pubs\/ft\/weo\/2012\/01\/weodata\/index.Aspx . Accessed 5 Nov 2013."},{"key":"2530_CR46","unstructured":"The World Factbook. Central Intelligence Agency, Washington D.C. 2013. https:\/\/www.Cia.Gov\/library\/publications\/the-world-factbook\/ . Accessed 14 Jan 2014."},{"issue":"12","key":"2530_CR47","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","volume":"17","author":"D Shepardson","year":"2013","unstructured":"Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, et al. Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. Int J Tuber Lung Dis. 2013;17(12):1531\u20137.","journal-title":"Int J Tuber Lung Dis"},{"key":"2530_CR48","unstructured":"May 2012 National Occupational Employment and Wage Estimates United States. Bureau of Labor Statistics, Washington D.C. 2013. http:\/\/www.Bls.Gov\/oes\/2012\/may\/oes_nat.Htm . Accessed 4 Dec 2013."},{"key":"2530_CR49","unstructured":"Global Drug Facility: Product catalogue. http:\/\/www.Stoptb.Org\/assets\/documents\/gdf\/who_stoptb_gdf_prod_a4.Pdf (2012). Accessed 15 Nov 2012."},{"key":"2530_CR50","unstructured":"International Drug Price Indicator Guide. Arlington, VA: Management Sciences for Health; 2013. http:\/\/erc.Msh.Org\/mainpage.Cfm?File=1.0.Htm&module=dmp&language=english . Accessed 5 Nov 2013."},{"key":"2530_CR51","unstructured":"Sanofi. Reduction of sanofi priftin phs 340(b) price. 2013. http:\/\/www.tbonline.info\/media\/uploads\/documents\/priftin_price_reduction_notice_20131210-1.pdf . Accessed 7 Mar 2015."},{"issue":"5","key":"2530_CR52","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3201\/eid2005.131037","volume":"20","author":"SM Marks","year":"2014","unstructured":"Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005\u20132007. Emerg Infect Dis. 2014;20(5):812\u201321.","journal-title":"Emerg Infect Dis"},{"key":"2530_CR53","unstructured":"Bureau of Labor Statistics: Consumer price index-all urban consumers, medical care, series id cuur0000sam. http:\/\/data.Bls.Gov\/cgi-bin\/srgate (2013). Accessed 20 Mar 2014."},{"issue":"15","key":"2530_CR54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","volume":"276","author":"MC Weinstein","year":"1996","unstructured":"Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276(15):1253\u20138.","journal-title":"JAMA"},{"key":"2530_CR55","first-page":"493","volume-title":"Handbook of practical program evaluation","author":"SR Cellini","year":"2010","unstructured":"Cellini SR, Kee JE. Cost-effectiveness and cost-benefit anlaysis. In: Wholey JS, Hatry HP, Newcomer KE, editors. Handbook of practical program evaluation. San Francisco: Jossey Bass; 2010. p. 493\u2013530."},{"key":"2530_CR56","unstructured":"Trottenberg P. Guidance on treatment of the economic value of a statistical life in U.S. department of transportation analyses. U.S. Department of Transportation. 2013. https:\/\/www.transportation.gov\/sites\/dot.dev\/files\/docs\/VSL%20Guidance%202013.pdf . Accessed 13 June 2013."},{"issue":"1","key":"2530_CR57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201308-1480OC","volume":"189","author":"ND Walter","year":"2014","unstructured":"Walter ND, Painter J, Parker M, Lowenthal P, Flood J, Fu Y, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med. 2014;189(1):88\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2530_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1164\/rccm.200608-1178OC","volume":"175","author":"KP Cain","year":"2007","unstructured":"Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD, Iademarco MF, et al. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med. 2007;175(1):75\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2530_CR59","first-page":"1","volume":"54","author":"National Tuberculosis Controllers Association","year":"2005","unstructured":"National Tuberculosis Controllers Association. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the national tuberculosis controllers association and CDC. MMWR Recomm Rep. 2005;54:1\u201347.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2530_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3\u201320.","journal-title":"Clin Microbiol Rev"},{"key":"2530_CR61","doi-asserted-by":"publisher","first-page":"e82727","DOI":"10.1371\/journal.pone.0082727","volume":"8","author":"JA Painter","year":"2013","unstructured":"Painter JA, Graviss EA, Hai HH, Nhung DT, Nga TT, Ha NP, et al. Tuberculosis screening by tuberculosis skin test or Quantiferon-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination. PLoS One. 2013;8:e82727.","journal-title":"PLoS One"},{"key":"2530_CR62","doi-asserted-by":"crossref","unstructured":"Chuke SO, Yen NT, Laserson KF, Phuoc NH, Trinh NA, Nhung DT, et al. Tuberculin skin tests versus interferon-gamma release assays in tuberculosis screening among immigrant visa applicants. Tuberc Res Treat. 2014;217969.","DOI":"10.1155\/2014\/217969"},{"issue":"3","key":"2530_CR63","doi-asserted-by":"publisher","first-page":"e56044","DOI":"10.1371\/journal.pone.0056044","volume":"8","author":"O Oxlade","year":"2013","unstructured":"Oxlade O, Pinto M, Trajman A, Menzies D. How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI. PLoS One. 2013;8(3):e56044.","journal-title":"PLoS One"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-2530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-015-2530-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-2530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T01:11:34Z","timestamp":1692148294000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-015-2530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-2530-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"1201"}}